Health Condition 1: O14- Pre-eclampsia
Conditions
Interventions
Intervention1: NIL: NOT APPLICABLE
Control Intervention1: NIL: NOT APPLICABLE
Sponsors
Intignus Biotech Pvt. Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Cases- Pregnant women aged 18 years and above with confirmed diagnosis of preeclampsia based on ACOG guidelines Controls- Age and time-matched normotensive pregnant women aged 18 years and above
Exclusion criteria
Exclusion criteria: Patients meeting any of the following exclusion criteria will not be eligible for participation in this study: 1. Unconscious or severely ill status 2. Having major fetal abnormality identified at the time of enrollment 3. Known bleeding disorder such as von Willebrand’s disease, peptic ulceration 4. Participation in another drug trial within 28 days before screening 5. Unable to provide written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity, specificity, positive/negative predictive values of Preeclampsia Screening KitTimepoint: Single Time Point | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Correlation of risk factor assessment between cases and controls 2. Comparison of biomarker levels detected by Preeclampsia Screening Kit and reference ELISA Timepoint: Single Time Point | — |
Countries
India
Contacts
Public ContactDr Neha Lasure
Intignus Biotech Pvt. Ltd.
Outcome results
None listed